Add to ORKGLung cancer remains the leading cause of cancer-related death worldwide with an estimated 900 000 new cases diagnosed each year in men and 330 000 in women [1]. Non-small-cell lung cancer (NSCLC) represent
Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung can...
Full list of author information is available at the end of the articleBackground Lung cancer is the ...
Treatment of advanced non small cell lung cancer (NSCLC) has been a challenge for oncologists in the...
Approximately one-third of all cancer-related deaths in Western countries are due to lung cancer. No...
Back Ground: Non small cell lung cancer (NSCLC) constitutes about 75-80 % of all lung cancer cases. ...
Full list of author information is available at the end of the articleBackground Lung cancer is the ...
Lung cancer is the most-common cause of cancer-related mortality worldwide and non-small cell Lung c...
The backbone of treatment in advanced non-small cell lung cancer is platinum-based doublet chemother...
Full list of author information is available at the end of the articleLung cancer is the leading cau...
Background: A combination of docetaxel (T) and capecitabine (X) showed synergistic effects in precli...
Lung cancer is one of the most commonly diagnosed cancers in the United States. It is estimated that...
Background: A combination of docetaxel (T) and capecitabine (X) showed synergistic effects in precli...
Objective: It is important to identify optimal regimens of cisplatin-based, third-generation che-mot...
NQO1 protein expression en Non-small cell lung cancer (NSCLC) accounted for ap- derm microtubule ass...
A retrospective comparison of docetaxel and paclitaxel as single-agent second-line chemotherapy for ...
Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung can...
Full list of author information is available at the end of the articleBackground Lung cancer is the ...
Treatment of advanced non small cell lung cancer (NSCLC) has been a challenge for oncologists in the...
Approximately one-third of all cancer-related deaths in Western countries are due to lung cancer. No...
Back Ground: Non small cell lung cancer (NSCLC) constitutes about 75-80 % of all lung cancer cases. ...
Full list of author information is available at the end of the articleBackground Lung cancer is the ...
Lung cancer is the most-common cause of cancer-related mortality worldwide and non-small cell Lung c...
The backbone of treatment in advanced non-small cell lung cancer is platinum-based doublet chemother...
Full list of author information is available at the end of the articleLung cancer is the leading cau...
Background: A combination of docetaxel (T) and capecitabine (X) showed synergistic effects in precli...
Lung cancer is one of the most commonly diagnosed cancers in the United States. It is estimated that...
Background: A combination of docetaxel (T) and capecitabine (X) showed synergistic effects in precli...
Objective: It is important to identify optimal regimens of cisplatin-based, third-generation che-mot...
NQO1 protein expression en Non-small cell lung cancer (NSCLC) accounted for ap- derm microtubule ass...
A retrospective comparison of docetaxel and paclitaxel as single-agent second-line chemotherapy for ...
Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung can...
Full list of author information is available at the end of the articleBackground Lung cancer is the ...
Treatment of advanced non small cell lung cancer (NSCLC) has been a challenge for oncologists in the...